GlassScriptPhysician profile
Zachary Keller
NPI 1962865170
$1,836.07
in general payments reported to CMS, 2019-2025
22 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.51 · 2021: $122 · 2022: $511 · 2023: $386 · 2024: $443 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.71 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $431.35 | 2022-2025 | |
| Astellas Pharma US INC | $155.50 | 2022-2024 | Veozah |
| Amgen INC. | $149.38 | 2020-2024 | Prolia, Evenity |
| Meditrina | $128.10 | 2022-2025 | |
| Abbvie INC. | $127.50 | 2021-2025 | |
| Millicent US INC | $118.83 | 2024-2025 | Femlyv, Intrarosa |
| Evofem Biosciences, INC. | $106.66 | 2024-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $102.58 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $86.03 | 2022-2024 | Third Wave, Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $71.25 | 2022-2025 | |
| Myovant Sciences INC. | $70.12 | 2021-2022 | |
| Novo Nordisk INC | $55.97 | 2023 | Wegovy |
| Exeltis, USA INC. | $49.93 | 2025 | Slynd |
| Ethicon US, LLC | $35.75 | 2022 | |
| Therapeuticsmd, INC. | $27.84 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.70 | 2022 | |
| Lupin INC. | $22.08 | 2021 | |
| Aspira Women'S Health INC | $17.23 | 2024 | Ova1 |
| Medtronic, INC. | $16.66 | 2022 | |
| Minerva Surgical, INC | $15.01 | 2025 | |
| Monaghan Medical Corporation | $13.08 | 2023 | Aerochamber |
| Pfizer INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.